ZA965904B - Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans - Google Patents

Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans

Info

Publication number
ZA965904B
ZA965904B ZA965904A ZA965904A ZA965904B ZA 965904 B ZA965904 B ZA 965904B ZA 965904 A ZA965904 A ZA 965904A ZA 965904 A ZA965904 A ZA 965904A ZA 965904 B ZA965904 B ZA 965904B
Authority
ZA
South Africa
Prior art keywords
gastroin
testinal
diarrhea
infections
humans
Prior art date
Application number
ZA965904A
Inventor
Margaret Ione Halpin Dohnalek
Karin Margaret Ostrom
Milo Duane Hilty
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of ZA965904B publication Critical patent/ZA965904B/en

Links

ZA965904A 1995-07-11 1996-07-11 Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans ZA965904B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US103695P 1995-07-11 1995-07-11

Publications (1)

Publication Number Publication Date
ZA965904B true ZA965904B (en) 1997-01-29

Family

ID=21694075

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA965904A ZA965904B (en) 1995-07-11 1996-07-11 Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans

Country Status (1)

Country Link
ZA (1) ZA965904B (en)

Similar Documents

Publication Publication Date Title
IL123131A0 (en) Use of indigestible oligosaccharides to prevent and treat diarrhea
PL326653A1 (en) Application of epinastin in pain relieving treatments
HK1015668A1 (en) Water dispersible and flushable absorbent article
ZA963287B (en) Modified anti-icam-1 antibodies and their use in the treatment of inflammation
AUPN033894A0 (en) Prevention of adverse behaviour in humans and animals
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
ZA9410078B (en) Methods of inhibiting atrophy of the skin and vagina
ZA9684B (en) Composition and use
IL122735A0 (en) Use of indigestible oligosaccharides to treat and prevent otitis media in humans
EP0811059A4 (en) Human chemokine beta-11 and human chemokine alpha-1
PL332579A1 (en) Application of 1-hydroxy-2-pyridinones in treating dermatological infections
ZA965904B (en) Use of indigestible oligosaccharides to prevent gastroin-testinal infections and reduce duration of diarrhea in humans
GB2298991B (en) In access to obscure and remote services
GB9602721D0 (en) Biologically active ureido derivatives useful in the treatment of multiple sclerosis
GB2307707B (en) Improvements in and relating to surfaces
IL108749A0 (en) Selective treatment of enteroviral-caused infections in humans
GB9510669D0 (en) Improvements in or relating to keep nets and their retention systems
GB9603657D0 (en) Improvements in the treatment of vaginal infections
GB9513255D0 (en) Improvements in and relating to furniture and other installations
ZA965619B (en) Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
GB9512703D0 (en) Composition and use
GB9616799D0 (en) Improvements in and relating to locking devices
GB9513279D0 (en) Improvements in and relating to furniture and other installations
GB9613013D0 (en) Improvements in and relating to furniture and other installations
GB9513413D0 (en) Improvements in and relating to furniture and other installations